Absci (ABSI) Times Interest Earned (2020 - 2026)

Absci (ABSI) reported Times Interest Earned of -$3.45 for Q1 2026, up 27.9% on a YoY basis from -$2.69 in Q1 2025, and up 79.39% sequentially from -$16.72 in Q4 2025.

Absci (ABSI) Times Interest Earned (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Times Interest Earned data on file, last reported at -$3.45 in Q1 2026.

  • For the quarter ending Q1 2026, Times Interest Earned rose 27.9% year-over-year to -$3.45; the trailing twelve-month figure through Mar 2026 stood at -$13.79 (up 29.28% YoY), and the FY2025 full-year result was -$1.13, up 18.85% from the prior year.
  • Times Interest Earned rose to -$3.45 in Q1 2026, from -$16.72 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $28.31 in Q4 2022 to a low of -$150.85 in Q4 2023.
  • A 5-year average of -$12.71 and a median of -$3.85 in 2022 frame the typical range for Times Interest Earned.
  • Peak annual rise in Times Interest Earned reached 97.23% in 2022, while the deepest fall reached 1495.07% in 2022.
  • Tracing ABSI's Times Interest Earned over 5 years: stood at $28.31 in 2022, then slumped by 632.79% to -$150.85 in 2023, then surged by 89.1% to -$16.45 in 2024, then declined by 1.67% to -$16.72 in 2025, then jumped by 79.39% to -$3.45 in 2026.
  • Business Quant data shows ABSI's Times Interest Earned at -$3.45 in Q1 2026, -$16.72 in Q4 2025, and -$3.08 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Absci 1.23 Bn 1.11 Bn - -3.45

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.45
Dec 31, 2025 -16.72
Sep 30, 2025 -3.08
Jun 30, 2025 -5.56
Mar 31, 2025 -4.78
Dec 31, 2024 -16.45
Sep 30, 2024 -1.34
Jun 30, 2024 -2.08
Mar 31, 2024 -0.42
Dec 31, 2023 -150.85
Sep 30, 2023 -8.13
Jun 30, 2023 -14.99
Mar 31, 2023 -8.54
Dec 31, 2022 28.31
Sep 30, 2022 -3.85
Jun 30, 2022 -3.47
Mar 31, 2022 -0.68
Dec 31, 2021 62.96
Sep 30, 2021 -0.30
Jun 30, 2021 -0.22